Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (151-160 of 515) with videos related to

Pageof 52
Sort By:
Leukemia|February 25, 2026
Correction: Peripheral blood flow cytometry-based definition of plasma cell leukemiaArwa Bohra, Rafla Hassan, Saurabh Zanwar, et al.
JMIR Research Protocols|October 16, 2023
Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the Pathanamthitta District of KeralaPanaparambil Azis Suhana, Lata Kusum, Jain Vij Shruti, et al.
British Journal of Haematology|February 21, 2006
FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myelomaShaji Kumar, Noopur Raje, Teru Hideshima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasmsAlla Keyzner, Anita D'Souza, Martha Lacy, et al.
American Journal of Hematology|June 10, 2009
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myelomaKah-Whye Peng, Ahmet Dogan, Julie Vrana, et al.
The Lancet. Haematology|December 23, 2014
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort studyRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.
Cancer|August 10, 2021
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or olderPashna N Munshi, David H Vesole, Andrew St Martin, et al.
Blood|March 28, 2012
Progression in smoldering Waldenstrom macroglobulinemia: long-term resultsRobert A Kyle, Joanne T Benson, Dirk R Larson, et al.
Leukemia|May 26, 2025
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell LeukemiaArwa Bohra, Rafla Hassan, Saurabh Zanwar, et al.
Blood|July 31, 2009
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myelomaCheng E Chee, Shaji Kumar, Dirk R Larson, et al.
Pageof 52

Showing results (151-160 of 515) with videos related to

Sort By:
Pageof 52
Leukemia|February 25, 2026
Correction: Peripheral blood flow cytometry-based definition of plasma cell leukemiaArwa Bohra, Rafla Hassan, Saurabh Zanwar, et al.
JMIR Research Protocols|October 16, 2023
Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the Pathanamthitta District of KeralaPanaparambil Azis Suhana, Lata Kusum, Jain Vij Shruti, et al.
British Journal of Haematology|February 21, 2006
FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myelomaShaji Kumar, Noopur Raje, Teru Hideshima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasmsAlla Keyzner, Anita D'Souza, Martha Lacy, et al.
American Journal of Hematology|June 10, 2009
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myelomaKah-Whye Peng, Ahmet Dogan, Julie Vrana, et al.
The Lancet. Haematology|December 23, 2014
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort studyRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.
Cancer|August 10, 2021
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or olderPashna N Munshi, David H Vesole, Andrew St Martin, et al.
Blood|March 28, 2012
Progression in smoldering Waldenstrom macroglobulinemia: long-term resultsRobert A Kyle, Joanne T Benson, Dirk R Larson, et al.
Leukemia|May 26, 2025
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell LeukemiaArwa Bohra, Rafla Hassan, Saurabh Zanwar, et al.
Blood|July 31, 2009
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myelomaCheng E Chee, Shaji Kumar, Dirk R Larson, et al.
Pageof 52